These data were analyzed with WGBS data from 36 other primary AML samples representing nine mutational categories, including five with biallelic loss-of-function mutations in TET2, and primary CD34+ cells from six healthy adults bone marrow donors [5]. This evidence concerns the gene TET2 and acute myeloid leukemia.